The earlier appearance of IgA anti-SARS-CoV-2 at higher levels than IgM or IgG systemically early after infection would not be predicted, based on the time required for transition from a primary to secondary response and the greater frequency of isotype switching to IgG compared to IgA. This evidence concerns the gene CD40LG and infection.